Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07524335
PHASE3

Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Sponsor: Montreal Heart Institute

View on ClinicalTrials.gov

Summary

In patients with subclinical coronary artery disease, the ASCAD-P study aims to assess the feasibility of a larger phase 3 pragmatic randomized controlled trial comparing prescription versus no prescription of low-dose aspirin in routine clinical practice.

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2026-05-01

Completion Date

2028-05-01

Last Updated

2026-04-15

Healthy Volunteers

No

Interventions

DRUG

Prescription of Aspirin

Aspirin 81 mg orally once daily

DRUG

No prescription

No prescription of aspirin 81 mg orally once daily

Locations (1)

Montreal Heart Institute

Montreal, Quebec, Canada